December 09, 2017 review Open access Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship Trends in Microbiology DOI: 10.1016/j.tim.2017.11.008 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 8 stored of 510 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Methicillin-resistant Staphylococcus aureus 2026 Nature Reviews Disease Primers review Medicine Antimicrobial Resistance in Staphylococcus 0 citations S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double‐blind randomized clinical trial in patients with mild to moderate atopic dermatitis 2026 British Journal of Clinical Pharmacology article Medicine Dermatology and Skin Diseases Open access 0 citations Lack of improvement after short‐term topical antistaphylococcal endolysin SA.100 therapy in patients with mild‐to‐moderate atopic dermatitis: Results from a randomized, vehicle‐controlled trial 2026 British Journal of Clinical Pharmacology article Medicine Dermatology and Skin Diseases Open access 1 citations Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition 2023 Experimental Dermatology article Medicine Nail Diseases and Treatments Open access 39 citations Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial 2023 International Journal of Molecular Sciences article Medicine Nail Diseases and Treatments Open access 13 citations Signal inhibitory receptor on leukocytes‐1 recognizes bacterial and endogenous amphipathic α‐helical peptides 2021 The FASEB Journal article Immunology and Microbiology Antimicrobial Peptides and Activities Open access 19 citations Association between nasal and nasopharyngeal bacterial colonization in early life and eczema phenotypes 2021 Clinical & Experimental Allergy article Medicine Dermatology and Skin Diseases Open access 5 citations Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial 2020 Journal of the American Academy of Dermatology article Medicine Dermatology and Skin Diseases Open access 51 citations 8 results References 0